Federal Supply Schedule 36F79723D009E

Award Date 11/15/22
Last Date to Order 4/14/23
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a multiple-award Federal Supply Schedule (FSS) contract to Heritage Pharmaceuticals Inc., doing business as Avet Pharmaceuticals Inc., to provide drugs, pharmaceuticals, and hematology related products. The $1.5 million Schedule 65 IB contract has a period of performance running through April 2028, allowing the VHA to efficiently procure various pharmaceutical and medical supplies to support healthcare...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB, which covers Drugs, Pharmaceuticals, and Hematology Related Products. The contract was awarded to HLS Therapeutics Inc., a for-profit manufacturer, on July 1, 2022 by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a ceiling value of $13,848,500.00 and a period of performance through June 30, 2027. It is a multiple award...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Nobelpharma America, LLC, a foreign-owned, self-certified small disadvantaged business. The FSS contract, under Federal Supply Class 65 I B, provides for the delivery of pharmaceutical and hematology-related products to VA facilities nationwide, with a ceiling value of $225,000 and a period of performance through May 2028. Additionally, Nobelpharma America, LLC was awarded a...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs. The prime contractor is Quallent Pharmaceuticals Health, LLC, a foreign-owned for-profit manufacturer of goods. The contract has a ceiling value of $25,000.00 and a period of performance through...
The federal contract IDV award is a multiple-award Federal Supply Schedule (FSS) contract under Schedule 65 IB for drugs, pharmaceuticals, and hematology-related products, awarded by the Department of Veterans Affairs to Vantive US Healthcare LLC. The contract has a ceiling value of $25,000 and a period of performance through February 1, 2025. The purpose of this IDV is to establish pre-competed procurement mechanisms that allow rapid acquisition of medical supplies and pharmaceuticals for the...
This federal contract is an Indefinite Delivery Vehicle (IDV) awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract is a Federal Supply Schedule (FSS) under Schedule 65 I B, which covers Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Avvisto Therapeutics LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $25,000.00 and...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The contracting agency is the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 12 (VISN 12). The prime contractor is Reata Pharmaceuticals, Inc., a for-profit organization. The contract has a ceiling value of $25,000.00 and a period of performance ending on October 23, 2023. It is a multiple...
This federal contract IDV is an interim agreement under the Federal Supply Schedule (FSS) 65 IB for Drugs, Pharmaceuticals, and Hematology Related Products, awarded to Avyxa Pharma, LLC, a for-profit limited liability company and manufacturer of goods. The contract has a total ceiling value of $25,000.00 and a period of performance through May 14, 2025. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs. The...
The federal contract IDV award is a Federal Supply Schedule contract with the Department of Veterans Affairs to provide pharmaceutical and hematology-related products. The 5-year, $250,000 multiple award IDV enables VA medical centers in Veterans Integrated Service Network 12 to procure hematology products without separate solicitations. The prime contractor is 60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company that develops and commercializes infectious disease medicines. 60...
  • 36F79723D009E
    Federal Supply Schedule
  • -
    Blanket Purchase Agreements

The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB for Drugs, Pharmaceuticals, and Hematology Related Products, awarded by the Department of Veterans Affairs (VA) to Heritage Pharmaceuticals Inc., doing business as Avet Pharmaceuticals Inc. The contract has a ceiling value of $25,000 and a period of performance through April 2023. Additionally, Heritage Pharmaceuticals holds a separate $1.5 million FSS Schedule 65 IB contract with the VA that runs through April 2028.

These contracts enable the VA's Veterans Health Administration to efficiently procure various pharmaceutical and medical supply products needed to support healthcare services for veterans through its network of medical centers. The contracts leverage Heritage Pharmaceuticals' established commercial capabilities as a foreign-owned, for-profit manufacturer of generic pharmaceutical goods. The initial $25,000 interim agreement and the larger $1.5 million contract provide the VA with a pre-qualified, centralized source for acquiring a range of drugs, pharmaceuticals, and hematology-related products to meet the needs of the Veterans Health Administration.

Generated 2/11/25, 10:08 AM